Phibro Animal Health (PAHC) Net Equity Issued and Repurchased (2015 - 2019)

Phibro Animal Health's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $793000.0 for Q1 2019.

• On a quarterly basis, Net Equity Issued and Repurchased fell 50.19% year-over-year to $793000.0 in Q1 2019; TTM through Jun 2019 was $1.1 million, a 80.1% decrease from a year earlier, with the FY2019 full-year figure at $1.1 million, down 80.1% from the prior year.
• Net Equity Issued and Repurchased advanced to $793000.0 in Q1 2019 per PAHC's latest filing, from $130000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $3.5 million in Q3 2017 and bottomed at $52000.0 in Q2 2016.
• The 5-year median for Net Equity Issued and Repurchased is $718000.0 (2015), against an average of $1.2 million.
• Across the five-year window, Net Equity Issued and Repurchased jumped 5594.23% in 2017 and sank 93.95% in 2018, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $1.4 million in 2015, then slumped by 96.25% to $52000.0 in 2016, then soared by 311.54% to $214000.0 in 2017, then slumped by 39.25% to $130000.0 in 2018, then surged by 510.0% to $793000.0 in 2019.
• Per Business Quant, the three latest PAHC Net Equity Issued and Repurchased figures stand at $793000.0 (Q1 2019), $130000.0 (Q4 2018), and $211000.0 (Q3 2018).